Do you recommend bevacizumab in platinum sensitive recurrences of epithelial ovarian cancer?

Or do you wait for platinum resistance?

Community PollStarted

What is your first choice for maintenance therapy in a patient with recurrent, platinum-sensitive ovarian cancer?

83 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer

Mednet MemberInvited Expert

Gynecologic Oncology · Vanderbilt University School of Medicine

Answered on

Bevacizumab was approved for use in combination with chemotherapy followed by continued bevacizumab maintenance in patients with platinum-sensitive recurrent ovarian cancer in December 2016. This approval was based on the findings of 2 studies, GOG-213 and the OCEANS trial. Both trials demonstrated ...

Join for free or sign in to see the full answer